• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Displaying 39-53 of 234,527 results

PRODRUGS OF PHENOLIC TRPV1 AGONISTS IN COMBINATION WITH LOCAL A...

Docket 16/303,082, U.S. Patent Application (Nov. 19, 2018)
Art Group1629
Case TypeUtility - 514/315000
Class514
Inventor John F. DONOVAN
Inventor Craig HUSFELD
Applicant CONCENTRIC ANALGESICS, INC.
...
cite Cite Docket

35 Motion: Patent Owner¿¿¿s Motion to Exclude Evidence 37 CFR ¿¿4264

Document IPR2019-00451, No. 35 Motion - Patent Owner¿¿¿s Motion to Exclude Evidence 37 CFR ¿¿4264 (P.T.A.B. Apr. 21, 2020)
EX1069 is hearsay because it is an out-of-court statement offered to prove the truth of the matter asserted, namely—as Petitioner states— related to Petitioner’s argument for a motivation to combine alcohols and rebuttal to Patent Owner’s showing of long-felt need.
EX1081 appears to be a webpage showing “Diazepam Prices and Coupons.” EX1081 is hearsay because it is an out-of-court statement offered to prove the truth of the matter asserted—purportedly, related to Dr. Wermeling’s argument of lack of secondary considerations and commercial success.
Dr. Wermeling does not set forth the principles used nor does he demonstrate the methods or 10 (finding improper incorporation by reference of block cites to expert declaration without sufficient explanation of those portions).
French et al., Pharmacopeial Standards and Specifications for Bulk Drugs and Solid Oral Dosage Forms, Journal of Pharmaceutical Sciences, December 1967, Vol.
EX1050 Table of Various Diazepam Solutions Described in or Modified From Sonne’s Example 11 (“DS11”) EX1065 Maggio, Provisional Patent Appl’n Serial No. 60632038 EX1069 Florida Regional Common EMS Protocols Field Guide, Jones and Barlett Publishers, MA (2005) EX1080 Valium® Tablet Label, Roche, January 2008 EX1081 Drug Prices from Internet
cite Cite Document

34 Motion: PETITIONERS MOTION TO EXCLUDE PURSUANT TO 37 CFR ¿¿ 4264c

Document IPR2019-00451, No. 34 Motion - PETITIONERS MOTION TO EXCLUDE PURSUANT TO 37 CFR ¿¿ 4264c (P.T.A.B. Apr. 21, 2020)

cite Cite Document

VISCOELASTIC ANALYSIS IN PATIENTS WITH DISEASE ASSOCIATED WITH CAR...

Docket 16/300,491, U.S. Patent Application (Nov. 9, 2018)

cite Cite Docket

DENTAL APPLIANCE HAVING ORNAMENTAL DESIGN

Docket 16/182,434, U.S. Patent Application (Nov. 6, 2018)

cite Cite Docket

CHEMICAL COMPOUNDS FOR TREATING ATHEROSCLEROSIS BY STABILIZING...

Docket 16/181,163, U.S. Patent Application (Nov. 5, 2018)

cite Cite Docket

COMPOSITIONS, METHODS, AND SYSTEMS FOR BEAD FORMATION USING IM...

Docket 16/178,430, U.S. Patent Application (Nov. 1, 2018)

cite Cite Docket

ENALAPRIL FORMULATIONS

Docket 16/177,159, U.S. Patent Application (Oct. 31, 2018)

cite Cite Docket

ISOTACHOPHORESIS FOR PURIFICATION OF NUCLEIC ACIDS

Docket 16/175,500, U.S. Patent Application (Oct. 30, 2018)

cite Cite Docket

SYSTEM AND METHOD FOR TREATMENT OF HEMORRHAGIC STROKE

Docket 16/167,288, U.S. Patent Application (Oct. 22, 2018)

cite Cite Docket

ARYL ETHERS AND USES THEREOF

Docket 16/164,653, U.S. Patent Application (Oct. 18, 2018)

cite Cite Docket

BACTERIAL LEADER SEQUENCES FOR PERlPLASMIC PROTEIN EXPRESSION

Docket 16/163,421, U.S. Patent Application (Oct. 17, 2018)

cite Cite Docket

METHODS AND SYSTEMS FOR QUANTUM READY AND QUANTUM ENABLED CO...

Docket 16/162,249, U.S. Patent Application (Oct. 16, 2018)

cite Cite Docket

TRISPECIFIC PROTEINS AND METHODS OF USE

Docket 16/159,554, U.S. Patent Application (Oct. 12, 2018)

cite Cite Docket

METHODS AND COMPOSITIONS RELATING TO MICROBIAL TREATMENT AND D...

Docket 16/159,536, U.S. Patent Application (Oct. 12, 2018)

cite Cite Docket
<< 1 2 3 4 5 6 7 ... >>